Evidence map›Paper›PMID 27067008›Full record

ReviewHerz2016

[Current state of treatment strategies for atrial fibrillation].

C Rogge, S Hilbert, N Dagres, G Hindricks

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herz, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

C RoggeAbteilung Rhythmologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
S HilbertAbteilung Rhythmologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
N DagresAbteilung Rhythmologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
G HindricksAbteilung Rhythmologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland. hindg@medizin.uni-leipzig.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation is the most common form of persistent cardiac arrhythmia with a greatly increasing prevalence due to an aging population and increasing cardiovascular risk factors. Apart from impairment of the quality of life atrial fibrillation is associated with a high morbidity, most importantly stroke and heart failure. The therapy is complex and aims at improving symptoms as well as the prevention of thromboembolic complications, heart failure and aggravating comorbidities. Based on individual patient characteristics and symptoms therapy is mainly based on heart rate control by pharmacological means or therapy for maintaining sinus rhythm. This treatment includes antiarrhythmic drugs and catheter ablation. Current research is aimed at the investigation of the electrophysiological mechanisms of recurrent therapy refractive atrial fibrillation and the question whether the maintenance of sinus rhythm can improve the prognosis of atrial fibrillation.

Indexed as

Anti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationCardiac Pacing, ArtificialCatheter AblationCombined Modality TherapyEvidence-Based MedicineHumansThromboembolismTreatment OutcomeAnti-Arrhythmia AgentsAnticoagulantsAnticoagulantsArrhythmogenic substrate analysisCatheter ablationHeart rate and rhythm controlSymptom based management

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.